Compile Data Set for Download or QSAR
Report error Found 75 of ic50 data for polymerid = 918
TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485677(US10940139, Example 02907 | US11000515, Compound T...)
Affinity DataIC50: 3.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485674(US10940139, Example 02900 | US11000515, Compound T...)
Affinity DataIC50: 3.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485673(US10940139, Example 02899 | US11000515, Compound T...)
Affinity DataIC50: 3.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485654(US10940139, Example 02511 | US11000515, Compound T...)
Affinity DataIC50: 5.00E+3nMAssay Description:Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as a His-tagged protein. Purified His...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485653(US10940139, Example 02471 | US11000515, Compound T...)
Affinity DataIC50: 5.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485654(US10940139, Example 02511 | US11000515, Compound T...)
Affinity DataIC50: 5.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485657(US10940139, Example 02639 | US11000515, Compound T...)
Affinity DataIC50: 5.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485653(US10940139, Example 02471 | US11000515, Compound T...)
Affinity DataIC50: 5.00E+3nMAssay Description:Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as a His-tagged protein. Purified His...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485657(US10940139, Example 02639 | US11000515, Compound T...)
Affinity DataIC50: 5.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485654(US10940139, Example 02511 | US11000515, Compound T...)
Affinity DataIC50: 5.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485653(US10940139, Example 02471 | US11000515, Compound T...)
Affinity DataIC50: 5.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485657(US10940139, Example 02639 | US11000515, Compound T...)
Affinity DataIC50: 5.00E+3nMAssay Description:Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as a His-tagged protein. Purified His...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485663(US10940139, Example 02734 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as a His-tagged protein. Purified His...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485666(US10940139, Example 02769 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485659(US10940139, Example 02680 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as a His-tagged protein. Purified His...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485664(US10940139, Example 02761 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485663(US10940139, Example 02734 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485658(US10940139, Example 02647 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485661(US10940139, Example 02708 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485659(US10940139, Example 02680 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485659(US10940139, Example 02680 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485658(US10940139, Example 02647 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485661(US10940139, Example 02708 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as a His-tagged protein. Purified His...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485655(US10940139, Example 02555 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485672(US10940139, Example 02808 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485661(US10940139, Example 02708 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485655(US10940139, Example 02555 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485663(US10940139, Example 02734 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485664(US10940139, Example 02761 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485658(US10940139, Example 02647 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as a His-tagged protein. Purified His...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485672(US10940139, Example 02808 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as a His-tagged protein. Purified His...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485666(US10940139, Example 02769 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485672(US10940139, Example 02808 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485655(US10940139, Example 02555 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as a His-tagged protein. Purified His...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485666(US10940139, Example 02769 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as a His-tagged protein. Purified His...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485664(US10940139, Example 02761 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as a His-tagged protein. Purified His...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485665(US10940139, Example 02767 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485656(US10940139, Example 02592 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485676(US10940139, Example 02903 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485675(US10940139, Example 02901 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485660(US10940139, Example 02704 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485662(US10940139, Example 02726 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485665(US10940139, Example 02767 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485667(US10940139, Example 02773 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485668(US10940139, Example 02799 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485669(US10940139, Example 02800 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485670(US10940139, Example 02803 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485671(US10940139, Example 02804 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485675(US10940139, Example 02901 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandPNGBDBM485662(US10940139, Example 02726 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as a His-tagged protein. Purified His...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

Displayed 1 to 50 (of 75 total ) | Next | Last >>
Jump to: